It will be interesting to determine whether this loop and the signaling bypass created by BRAF-dependent PAX3 phosphorylation is also operative in other tissues and in cancer cells such as rhabdomyosarcoma and melanoma cells, which would offer new refined therapeutic approaches. Here, BRAF is linked to cancer.